home / stock / rnlx / rnlx news

RNLX News and Press, Renalytix AI plc

Stock Information
Company Name: Renalytix AI plc
Stock Symbol: RNLX
Market: NASDAQ
Website: renalytix.com
Menu
RNLX RNLX Quote RNLX Short RNLX News RNLX Articles RNLX Message Board
Get RNLX Alerts

News, Short Squeeze, Breakout and More Instantly...
RNLX - US Companies Moving the Markets, Evening edition
Thu, Jul 11, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...
RNLX - US Companies Moving the Markets, Morning edition
Thu, Jul 11, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 106.5% to $1.38 on volume of 71,739,314 shares Renalytix plc (RNLX) rose 41.4% to $0.4269 on volume of 54,892,134 shares Maxeon Solar Technologies Ltd. (MAXN) fell 7.4% to $0.1951 on volume of 45...

RNLX - Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US

LONDON and NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces ...

RNLX - Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination

LONDON and NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (Nasdaq: RNLX) (LSE: RENX) announces that it has formally submitted a hearing request to the Nasdaq Hearings Panel (the “Panel”), which request has now stayed the suspension of the Company's secu...
RNLX - Medicare Issues Final Coverage Determination for kidneyintelX.dkd

LONDON and NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that on June 13, 2024 Medicare issued a final Local Coverage Determination ("LCD") for the Company's kidneyintelX.dkd testing. The final LCD can be accessed at LCD - KidneyInt...

RNLX - Renalytix files for selling of 26.8M shares by stockholders

2024-06-05 16:55:47 ET More on Renalytix AI Renalytix Plc (RNLX) Q3 2024 Earnings Call Transcript Renalytix announces $1M registered direct offering, financing with expected size of up to $4M Seeking Alpha’s Quant Rating on Renalytix AI Historical earn...

RNLX - Renalytix Plc (RNLX) Q3 2024 Earnings Call Transcript

2024-05-15 18:15:29 ET Renalytix Plc (RNLX) Q3 2024 Results Conference Call May 15, 2024 08:30 AM ET Company Participants Peter DeNardo - CapComm Partners James McCullough - Chief Executive Officer James Sterling - Chief Financial Officer Howard Doran - Chief...
RNLX - Renalytix AI GAAP EPS of -$0.08 beats by $0.01, revenue of $0.54M misses by $0.56M

2024-05-15 07:07:14 ET More on Renalytix AI Renalytix announces $1M registered direct offering, financing with expected size of up to $4M Renalytix approached by potential buyer, stock rallies 28% Seeking Alpha’s Quant Rating on Renalytix AI Historical...

RNLX - Expected US Company Earnings on Wednesday, May 15th, 2024

Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...

RNLX - Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024

LONDON and NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today repor...
Next 10